Jonathan F. Atzen
Director/Board Member at Mytogen, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William M. Caldwell | M | 76 |
Mytogen, Inc.
Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA. | 6 years |
George Fitzgerald | M | - |
Mytogen, Inc.
Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Barrett Evans | M | 52 |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
Gary H. Rabin | M | 58 | 7 years | |
Michael West | M | 71 | - | |
Alan C. Shapiro | M | 78 | 11 years | |
Ivan Wolkind | M | 56 | 3 years | |
Jeffrey S. Conrad | M | 49 |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
Erkki Ruoslahti | M | 84 | 6 years | |
Rita Parker | F | - | - | |
Victor Voebel | M | 74 |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
Pedro Huertas | M | 69 | - | |
Alan G. Walton | M | 87 | 3 years | |
Mark A. Franzen | M | - |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
E. Greg McCartney | M | 72 |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
Antony Stefan Dyakowski | M | - |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
James Gordon Stewart | M | 71 | 1 years | |
Robert W. Peabody | M | 69 | 9 years | |
Ian B. Woods | M | - |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
Robert F. Lutz | M | 86 |
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | - |
Stephen Price | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 21 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan F. Atzen
- Personal Network